Participants 27 110 6
cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
Participants 122 136 4
Young children
Participants 280 306 5
children <6 months of age.
Participants 631 699 6
administered intranasally to healthy children 6 to <24 weeks of age.
Participants 708 887 6
Healthy infants aged 6 to <16 weeks and 16 to <24 weeks, respectively, were randomly assigned to receive 2 doses of influenza vaccine, or placebo intranasally 35 +/- 7 days apart.
Participants 1041 1099 3
infants aged 6 to <16 weeks, 31 received influenza vaccine
Participants 1132 1213 3
those aged 16 to <24 weeks, 30 received influenza vaccine and 31 received placebo
Participants 1627 1658 3
children 6 to <16 weeks of age,
Participants 1734 1764 3
infants 6 to <24 weeks of age.
Participants 1856 1880 3
infants <6 months of age
